38 h. ago 'Add' Jindal Steel Shares Maintains PL Capital Post Strong Q1, Hikes Target Price

PL Capital has reiterated its 'Accumulate' stance and lifted the target price, citing improved earnings visibility and project ramp-ups.

Events

4 d. ago Siemens Q3 Review: Motilal Oswal Retains 'Netural' Stance On The Stock, Cuts Target Price

Motilal Oswal retains Neutral rating on the stock with a revised target price of Rs 3,300.

Events

8 d. ago 'Add' Cera Sanitaryware Shares Maintains PL Capital Post Q1 Results

PL Capital downward revises FY26/FY27E earnings estimate by 1.9%/2.8% and reduces target price, based on 30x FY27E earnings

Events

8 d. ago Lupin Q1 Review: Dolat Capital Maintains 'Add', But Cuts Target Price

Timely launches of injectables and inhalation products will be further triggers to the brokerage's earnings estimates.

Events

8 d. ago Container Corp Q1 Review: Jefferies Cuts Target Price As Weak Volume Growth Weigh On Operating Profit

Jefferies has cut the target price of Container Corp to Rs 650 apiece from Rs 825 apiece. The current target price implied a 12.3% downside from Wednesday's close price.

Economics

9 d. ago 'Add' Berger Paints Shares Maintains Dolat Capital Post Q1 Results

Berger Paints gross margin expanded by 150 bps YoY to 41.4% due to favorable raw material trends and improved product mix.

Politics

9 d. ago Alembic Pharma Q1 Review: Dolat Capital Maintains 'Add', Revises Target Price

Dolat Capital maintains 'Accumulate' rating on Alembic Pharma and revises target price.

Events

1 week ago Dr. Reddy's Laboratories Price Target Cut By Citi Over Intensifying Generic Competition

Citi notes that market expectations for Dr. Reddy's Semaglutide opportunity may be too optimistic.

Events

4 w. ago Angel One Is Still A 'Buy' For Motilal Oswal Post Q1 Results, But Cuts Target Price

While the near-term outlook is not encouraging for the broking segment, the structural story remains intact, adds Motilal Oswal

Economics

4 w. ago Axis Bank Sees Barrage Of Price Target Cuts After Rise In Q1 Provision, Worsening Asset Quality

While most maintain a positive long-term stance, the near-term outlook has been clouded by volatile earnings and operational challenges.

Economics